Study Participants |
|
|
|
Previous pathogenic or likely pathogenic clinical
testing |
8 |
|
Sequenced |
43 |
|
Total analyzed in study |
51 |
|
Gender |
|
|
|
Female |
33 (55) |
|
Male |
18 (35) |
|
Mean age at gastric cancer diagnosis, years |
|
46.9 years (range 17–85) |
|
Racial and Ethnic Categories*
|
|
|
|
White (Non-Hispanic Caucasian) |
25 (49) |
|
Hispanic or Latino |
16 (31) |
|
Asian |
8 (16) |
|
Black or African-American |
1 (2) |
|
American Indian |
1 (2) |
|
Family history |
|
|
|
First-degree relative (FDR) with gastric cancer |
19 (37) |
|
More than one FDR with gastric cancer |
9 (18) |
|
FDR and second degree relative (SDR) with gastric
cancer |
7 (14) |
|
FDR and/or SDR with gastric cancer |
26 (51) |
|
FDR and/or SDR with one or more of the following cancers:
Breast, colorectal, thyroid, uterine, leukemia, gastric, pancreatic, or
ovarian |
45 (88) |
|
Histology |
|
|
|
Adenocarcinoma, Diffuse type |
23 (45) |
|
Adenocarcinoma, Intestinal type |
9 (18) |
|
Adenocarcinoma, not specified or only noted as
indeterminate/poorly differentiated |
4 (8) |
|
Gastrointestinal Stromal Tumor |
2 (4) |
|
Unknown (presumed adenocarcinoma) |
13 (25) |
|
Participants with other solid tumor primary
cancers |
17 (33) |
|
Breast |
7 (14) |
|
Colorectal |
3 (6) |
|
Sarcoma |
2 (4) |
|
Ovarian, prostate, or uterine, carcinoid, or bladder |
5 (10) |